A. Pavlovski

Tumor Evolution Inferred by Patterns of microRNA Expression through the Course of Disease, Therapy, and Recurrence in Breast Cancer

E. Domany, R. Berger, A. Yosepovich, 2016, Clinical Cancer Research.

Chemotherapy Shifts the Balance in Favor of CD8+ TNFR2+ TILs in Triple-Negative Breast Tumors

I. Barshack, T. Meshel, M. Dadiani, 2021, Cells.

Divergence of mutational signatures in association with breast cancer subtype

A. Yosepovich, I. Barshack, E. Friedman, 2022, Molecular carcinogenesis.

Correction to: ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis

I. Barshack, E. Eyal, N. Kol, 2020, Breast Cancer Research.

ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis

I. Barshack, E. Eyal, N. Kol, 2020, Breast Cancer Research.

TNFR2+ TILs are significantly associated with improved survival in triple-negative breast cancer patients

S. Wiemann, I. Barshack, M. Dadiani, 2020, Cancer Immunology, Immunotherapy.